Literature DB >> 4386370

The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

J W Foo, A Jowett, A Stafford.   

Abstract

1. The potencies of some beta-adrenoreceptor blocking drugs in reducing noradrenaline uptake by the isolated heart were compared with their potencies in reducing the release of noradrenaline from the heart by tyramine.2. Of the drugs tested, propranolol, pronethalol and dichloroisoprenaline were the most potent in blocking uptake and release of noradrenaline, although none was at potent as cocaine; MJ 1999 and I.C.I. 50172 were only weakly effective.3. Pronethalol and dichloroisoprenaline each reduced release of noradrenaline by tyramine in the concentration range (10(-7)-10(-6)M) where blockade of responses to tyramine was apparent; with these drugs both reduction of noradrenaline release and beta-receptor blockade contribute to the reduction in responses to tyramine.4. Potency of beta-receptor blocking drugs in reducing noradrenaline uptake is unrelated to potency in blocking beta-receptors; Kö 592 blocks beta-receptors without affecting noradrenaline uptake.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4386370      PMCID: PMC1703465          DOI: 10.1111/j.1476-5381.1968.tb07957.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  INHIBITION OF SYMPATHOMIMETIC EFFECTS ON THE HEART.

Authors:  B G BENFEY; D R VARMA
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  [THE EFFECT OF DRUGS ON THE ELIMINATION OF NORADRENALIN FROM PERFUSION FLUID AND NORADRENALIN UPTAKE IN THE ISOLATED HEART].

Authors:  R LINDMAR; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

4.  The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain.

Authors:  L M MCEWEN
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

5.  A new and sensitive bioassay for catecholamines.

Authors:  I S De la Lande; J A Harvey
Journal:  J Pharm Pharmacol       Date:  1965-09       Impact factor: 3.765

Review 6.  Release and uptake of noradrenaline in adrenergic nerve granules.

Authors:  U S von Euler
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

7.  Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion.

Authors:  T C Westfall
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

8.  Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).

Authors:  P Aramendía; A J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  1967-02       Impact factor: 4.030

9.  THE INFLUENCE OF PHENOXYBENZAMINE ON THE STORAGE OF NORADRENALINE IN RAT AND CAT TISSUES.

Authors:  J FARRANT; J A HARVEY; J N PENNEFATHER
Journal:  Br J Pharmacol Chemother       Date:  1964-02

10.  A hypothesis concerning the effect of cocaine on the action of sympathomimetic amines.

Authors:  W H MACMILLAN
Journal:  Br J Pharmacol Chemother       Date:  1959-09
  10 in total
  18 in total

1.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Smoking and catecholamine and c-AMP concentrations in the coronary circulation of man and the effect of oxprenolol.

Authors:  R H Robson; D C Fluck
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

3.  Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.

Authors:  G Richardt; U Lumpp; M Haass; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.

Authors:  E J Mylecharane; C Raper
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

5.  The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.

Authors:  B Lemmer; R Saller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Comparative chronotropic activity of beta-adrenoceptive antagonists.

Authors:  A M Barrett; J Carter
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

7.  A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.

Authors:  J G Papp; E M Williams
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

8.  The binding of [3H]-noradrenaline and [14C]-propranolol to synaptosomal fractions of rat brain homogenates [proceedings].

Authors:  B A Hemsworth; J A Street
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

9.  Role of adrenergic neurone blockade in the hypotensive action of propranolol.

Authors:  S Eliash; M Weinstock
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.